Diagnostic value and clinical significance of serological markers in Tunisian patients with inflammatory bowel diseases

Annales de Biologie Clinique

Volumn 68, Issue 5, 2010, Pages 577-583

  Bouzid, Dorra ^a   Haddouk, Samy ^a   Amouri, Ali ^b   Hmida, Youssef Ben Haj ^a   Boukthir, Samia ^a   Ayed, Mourad Ben ^a   Tahri, Nabil ^b   Masmoudi, Hatem ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

ASCA; Crohn's disease; Inflammatory bowel disease; NANA; Ulcerative colitis

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; NEUTROPHIL; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLAMMATORY BOWEL DISEASES; MALE; NEUTROPHILS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 77958505500     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2010.0471     Document Type: Article

References (44)

1. Daniel K, Podolsky MD. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-29.
2. Bossuyt X. Serologic markers in inflammatory bowel disease. Clinic Chem 2006; 52: 171-81. (Pubitemid 43185477)
3. Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel disease: Gadget or magic ? World J Gastroenterol 2007; 13: 2028-36. (Pubitemid 46795837)
4. Giaffer MH, Clark A. Holdworth. Antibodies to Saccharomyces cervisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992; 30: 1071-5.
5. Roozendaal A, Kallenberg CGM, Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel, disease (IBD). Clin Exp Immunol 1999; 116: 206-13.
6. Cambridge G, Rampton DS, Stevens TR, McCarthy DA, Kamm M, Leaker B. Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut .1992; 33: 668-74.
7. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Antineutrophil cytoplasmic antibody in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-6.
8. Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower-Rousseau C, Paris JC, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992; 16: 656-60.
9. Rump JA, Scholmerich J, Gross V, Roth M, Helfesrieder R, Rautmann A, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol 1990; 181: 406-13.
10. Terjung B, Spengler U, Sauerbruch T, Worman HJ. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000; 119: 310-22. (Pubitemid 30621981)
11. Sendid B, Quintan JF, Charrier G, Goulet O, Cortot A, Grandbastien B, et al. Anti- Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's Disease. Am J Gastroenterol 1998; 93: 1306-10. (Pubitemid 29076932)
12. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 730-4. (Pubitemid 32240723)
13. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-91. (Pubitemid 28277217)
14. Podolsky DK. Inflammatory bowel, disease. N Engl J Med 1991; 325: 928-37.
15. Silverberg MS, Satsangi J, Ahmed T, Arnott ID, Bernstein CN, Brant SR, et al. Toward and integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Monterai World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A): 5-36.
16. Main J, Mckenzie H, Yeamman. G, Kerr M, Robonson D, Pennington C, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. Br Med J 1988; 297: 1105-6.
17. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol .1990; 86: 202-10. (Pubitemid 20288725)
18. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EJ. Diagnostic accuracy of serological, assays in pediatric inflammatory bowel, disease. Gastroenterology 1998; 115: 822-9. (Pubitemid 28452928)
19. Verneire S, Joosens S, Peeters M, Monsuur F, Maznen G, Bossuyt X, et al. Comparative study of ASCA (Anti-Saccharomyces cervisiae) assays in inflammatory bowel disease. Gastroenterology 2001; 120: 827-33. (Pubitemid 32193179)
20. Joossens S, Daperno M, Shums Z, Van Steen K, Goeken JA, Trapani C, et al. Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis. Clin Chem 2004; 50: 1422-5. (Pubitemid 38970654)
21. Nassberger L, Ljungh. A, Schumacher G, Kollberg B. β-Glucuronidase antibodies in ulcerative colitis. Lancet 1992; 340: 734-5.
22. Hauschild S, Schmitt WH, Csemok E, Flesch BK, Rautmann A, Gross WL. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel, diseases. Adv Exp Med Biol 1993; 336: 245-51. (Pubitemid 24004923)
23. Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel, disease and associated disorders. Clin Exp Immunol 1996; 104: 54-9. (Pubitemid 26103413)
24. Sugi K, Saitoh O, Matsuse R, Tabata K, Uchida K, Kojima K, et al. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Am J Gastroenterol 1999; 94: 1304-12. (Pubitemid 29214646)
25. Anand V, Russell AS, Tsuyuki R. Fedorak R. Perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cervisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis. Can J Gasteroenterol 2008; 22: 33-6. (Pubitemid 351385649)
26. Saibeni S, Folli C, De Franchis R, Borsi G, Vecchi M, Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Digest Liver Dis 2003; 35: 862-8. (Pubitemid 41070491)
27. Mokrowiecka A, Daniel P, Slomka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepatogastroenterology 2009; 56: 162-6.
28. Barnes RMR, Allan S, Aylor-Robonson CH, Finn R, Johnson PM. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: is IgA antibody a marker for Crohn's disease ? Int Arch Allergy Appl Immunol 1990; 92: 9-15. (Pubitemid 20359721)
29. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 1006-9.
30. Nakamura RM, Matsutani M, Barry M. Advances in clinical laboratory tests for inflammatory bowel, diseases. Clin Chim Acta 2003; 335: 9-20.
31. Desplat-Jégo S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, et al. Update on anti-Saccharomyces cerevisiae, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World J Gastroenterol 2007; 13: 2312-8. (Pubitemid 46860731)
32. Reese GE, Constantinides VA, Similis C, Darzi AW, Orchard TR, Fazio VW, et al. Diagnostic precision of anti- Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 2006; 101: 2410-22.
33. Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing is suspected pediatric inflammatory bowel, disease. Am J Gastroenterol 2001; 96: 758-65. (Pubitemid 32240727)
34. Sandborn WJ, Loftus Jr EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, et al. Evaluation of serological disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease, Inflamm Bowel Dis 2001; 7: 192-201. (Pubitemid 32776511)
35. Linskens RK, Mallant-Hent RC, Grouthuismink ZM, Bakker-Jonges LE, van de Merwe JP, Hooijkaas H, et al. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods. Eur J Gastroenterol Hepatol 2002; 14: 1013-8.
36. Reumaux D, Sendid B, Poulain D, Duthilleul P, Dewit O, Colombel JF. Serological markers in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2003; 17: 19-35.
37. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan. SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47: 487-96.
38. Linberg E, Magnusson KE, Tysk C, Jarnerot G. Antibody (IgG, IgA and IgM) to baker's yeast (Saccharomyces cerevisiae Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbimin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut 1992; 33: 909-13.
39. Ferry GD. The use of antineutrophil cytoplasmic antibodies to determine clinical patterns of ulcerative colitis in children, J Pediatr Gastroenterol Nutr 1998; 26: 475-7.
40. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: result of a pulot study. Mayo Clin Proc 1996; 71: 431-6.
41. Lindgren S, Floren CH, Lindhagen T, Starek M, Stewenius J, Nassbergerl V. Low prevalence of antineutrophil cytoplasmic antibodies in ulcerative colitis patients with long-term remission. Eur J Gastroenterol Hepatol 1995; 7: 563-8.
42. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci GM, Campieri M, et al. P-ANCA and developement of pouchitis in ulcerative colitis after proctocolectomy and ileoanal puch anastomosis. Lancet 1994; 344: 886-7. (Pubitemid 24290397)
43. Sandborn WJ, Landers WJ, Tremaine WJ, Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic poucitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 740-7.
44. Perri F, Annese V, Piepoli A, Napolitano G, Lambardi G, Ciavarella G, et al. HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol 1998; 30: 56-61. (Pubitemid 28220702)